Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Rotavirus Prophylaxis Global Market Report 2024

Rotavirus Prophylaxis Global Market Report 2024 – By Treatment (Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments), By Route of Administration (Oral, Parenteral, Other Route of Administrations), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Rotavirus Prophylaxis Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Rotavirus Prophylaxis Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Rotavirus Prophylaxis Market Definition And Segments

Rotavirus prophylaxis refers to the prevention of rotavirus infection through vaccination, which protects infants and young children from a highly infectious illness that causes stomach and bowel inflammation. The purpose is to protect from person from any severity.

The main types of treatment for rotavirus prophylaxis are rotarix, rotavac, rotavin-m1, oral rehydration fluid and others. Rotavirus is a virus that causes severe stomach or intestinal sickness such as fever, vomiting and diarrhea. The various routes of administration are oral, parenteral and others channeled through hospital pharmacy, retail pharmacy, online pharmacy and others. The end users are hospitals, specialty clinics, home care and others.

The rotavirus prophylaxis market covered in this report is segmented –

1) By Treatment: Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments

2) By Route of Administration: Oral, Parenteral, Other Route of Administrations

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

The rotavirus prophylaxis market size has grown rapidly in recent years. It will grow from $8.15 billion in 2023 to $9.05 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to vaccine access and equity, emerging rotavirus strains, r&d investments, public health preparedness.

The rotavirus prophylaxis market size is expected to see strong growth in the next few years. It will grow to $13.24 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to gastrointestinal disease burden, global expansion, vaccination programs, vaccine confidence. Major trends in the forecast period include next-generation vaccines, combination vaccines, vaccine delivery innovation, global immunization collaboration.

Rising Vaccine Courses Powering Growth In The Rotavirus Prophylaxis Market

The increasing vaccine courses are expected to propel the growth of the rotavirus prophylaxis market going forward. A vaccine course is a specific dose of vaccine that is meant to be given to a person to produce protection from a particular disease. The vaccine course dosage stimulates the immunological response, providing excellent protection against rotavirus infection. This increased immunity minimizes the risk of diseases and improves the vaccine's overall efficacy. For instance, in January 2022, according to a report published by the United Nations International Children's Emergency Fund (UNICEF), a US-based provider of humanitarian and developmental help to children, around 5.71 million courses of RV1-5 frozen rotavirus vaccine were produced 2022, with a projected increase to 9.31 million courses by 2028. Furthermore, 5.29 million courses of RV5-2 lyophilized rotavirus vaccines were manufactured in 2022, with a projected rise to 6.13 million courses by 2028. Therefore, the increasing number of vaccines will drive the rotavirus prophylaxis market.

Institutional Funding Drives Growth In The Rotavirus Prophylaxis Market

Funding from institutions is expected to propel the growth of rotavirus prophylaxis market. Funding from institutions refers to the provision of resources in the form of money, effort, or time, to finance a need, program, or project. Rotavirus’ increasing cases attracted funding from government and private organizations. This funding provides financial and technical assistance across different development phases of rotavirus vaccine and oral medication. For instance, in April 2022, Indiana University, a US-based public research university, received $1.2 million grant from venture capital firm, GIVAX Inc. to develop a new technology for a combination oral rotavirus-norovirus vaccine for infants. The technology expands the widely available rotavirus vaccine to include protection against norovirus, a highly contagious virus that can cause severe vomiting and diarrhea in young children. Therefore, increasing the availability of funding will boost the rotavirus prophylaxis market.

Major players in the rotavirus prophylaxis market are Pfizer Inc., Johnson & Johnson, Merck & Co., Novartis AG, Sanofi SA, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd., Astellas Pharma Inc., CSL Limited, Bharat Biotech International Limited, Daiichi Sankyo Co. Ltd., Lupin Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., Zydus Lifescience Ltd., Emergent BioSolutions Inc., Hualan Biological Engineering Inc., Biocad Biopharmaceutical Co., Bharat Serums and Vaccines Limited, Biological E Limited, PT Bio Farma, Panacea Biotec Ltd., Shanghai Institute of Biological Products (SIBP).

Impact Of High Vaccine Costs On The Growth Of The Rotavirus Prophylaxis Market

The high cost of vaccines is hindering the growth of the rotavirus prophylaxis market during forecast period. High vaccine prices can make rotavirus vaccines unaffordable for individuals and families, especially in low- and middle-income countries with limited healthcare budgets. This affordability barrier can reduce vaccine demand and coverage rates. For instance, in May 2021, according to the National Library of Medicine, a US-based medical library, between $26 and $75 per vaccination for each individual. Therefore, the high cost of vaccines is hindering the growth of the rotavirus prophylaxis market.

Vaccine Development And Approvals In The Rotavirus Prophylaxis Market

Major companies operating in the rotavirus prophylaxis market are developing vaccines to meet customer requirements. Vaccine approvals involve a rigorous process that includes multiple development and testing stages. These approvals are essential in ensuring that vaccines are safe and effective for preventing this viral illness, particularly in infants and young children. For instance, in November 2022, GlaxoSmithKline PLC, a UK-based pharmaceutical and biotechnology company, announced that the Food and Drug Administration (FDA) had approved an oral-dosing applicator-only presentation (liquid formulation) of ROTARIX (Rotavirus Vaccine, Live and Oral), that prevents rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4 and G9) in infants. The novel oral-dosing applicator-only presentation is entirely liquid and must not be reconstituted before use. ROTARIX lyophilized and liquid formulations are administered orally in a two-dose series, contain the same live, human-attenuated rotavirus strain and are made using comparable techniques.

Collaboration Between Aspen Pharmacare And Serum Institute Of India For Vaccine Production In Africa

In August 2022, Aspen Pharmacare Holdings Limited (APN), a South Africa-based pharmaceutical company, collaborated with Serum Institute of India Pvt. Ltd. The collaboration with the Serum Institute of India (SII) was to manufacture and sell four Aspen-branded vaccines for Africa. The partnership aimed to strengthen Africa's health manufacturing capacity and provide access to affordable vaccines for the African population. Serum Institute of India Pvt. Ltd is an India-based vaccine manufacturer, including rotavirus.

North America was the largest region in the rotavirus prophylaxis market in 2023. The regions covered in rotavirus prophylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the rotavirus prophylaxis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rotavirus prophylaxis market consists of revenues earned by entities by providing services such as vaccination, clinical management, awareness programs and diagnosis. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The rotavirus prophylaxis market research report is one of a series of new reports from The Business Research Company that provides rotavirus prophylaxis market statistics, including rotavirus prophylaxis industry global market size, regional shares, competitors with a rotavirus prophylaxis market share, detailed rotavirus prophylaxis market segments, market trends and opportunities and any further data you may need to thrive in the rotavirus prophylaxis industry. This rotavirus prophylaxis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Rotavirus Prophylaxis Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $9.05 billion
Revenue Forecast In 2033 $13.24 billion
Growth Rate CAGR of 10% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Treatment: Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments
2) By Route of Administration: Oral, Parenteral, Other Route of Administrations
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Johnson & Johnson; Merck & Co.; Novartis AG; Sanofi SA; Astra Zeneca Pharmaceuticals LP; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Sinovac Biotech Ltd.; Astellas Pharma Inc.; CSL Limited; Bharat Biotech International Limited; Daiichi Sankyo Co. Ltd.; Lupin Limited; Mitsubishi Tanabe Pharma Corporation; Serum Institute of India Pvt. Ltd.; Zydus Lifescience Ltd.; Emergent BioSolutions Inc.; Hualan Biological Engineering Inc.; Biocad Biopharmaceutical Co.; Bharat Serums and Vaccines Limited; Biological E Limited; PT Bio Farma; Panacea Biotec Ltd.; Shanghai Institute of Biological Products (SIBP)
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Rotavirus Prophylaxis Market Characteristics

    3. Rotavirus Prophylaxis Market Trends And Strategies

    4. Rotavirus Prophylaxis Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Rotavirus Prophylaxis Market Size and Growth

    5.1. Global Rotavirus Prophylaxis Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Rotavirus Prophylaxis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Rotavirus Prophylaxis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Rotavirus Prophylaxis Market Segmentation

    6.1. Global Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Rotarix

    Rotavac

    Rotavin-M1

    Oral Rehydration Fluid

    Other Treatments

    6.2. Global Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Parenteral

    Other Route of Administrations

    6.3. Global Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacy

    Retail Pharmacy

    Online Pharmacy

    Other Distribution Channels

    6.4. Global Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Specialty Clinics

    Homecare

    Other End-Users

    7. Rotavirus Prophylaxis Market Regional And Country Analysis

    7.1. Global Rotavirus Prophylaxis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Rotavirus Prophylaxis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Rotavirus Prophylaxis Market  

    8.1. Asia-Pacific Rotavirus Prophylaxis Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Rotavirus Prophylaxis Market  

    9.1. China Rotavirus Prophylaxis Market Overview  

    9.2. China Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Rotavirus Prophylaxis Market  

    10.1. India Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Rotavirus Prophylaxis Market  

    11.1. Japan Rotavirus Prophylaxis Market Overview  

    11.2. Japan Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Rotavirus Prophylaxis Market  

    12.1. Australia Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Rotavirus Prophylaxis Market  

    13.1. Indonesia Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Rotavirus Prophylaxis Market  

    14.1. South Korea Rotavirus Prophylaxis Market Overview  

    14.2. South Korea Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Rotavirus Prophylaxis Market  

    15.1. Western Europe Rotavirus Prophylaxis Market Overview

    15.2. Western Europe Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Rotavirus Prophylaxis Market  

    16.1. UK Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Rotavirus Prophylaxis Market  

    17.1. Germany Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Rotavirus Prophylaxis Market  

    18.5. France Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Rotavirus Prophylaxis Market  

    19.9. Italy Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Rotavirus Prophylaxis Market  

    20.13. Spain Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Rotavirus Prophylaxis Market  

    21.1. Eastern Europe Rotavirus Prophylaxis Market Overview

    21.2. Eastern Europe Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Rotavirus Prophylaxis Market  

    22.1. Russia Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Rotavirus Prophylaxis Market  

    23.1. North America Rotavirus Prophylaxis Market Overview

    23.2. North America Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Rotavirus Prophylaxis Market  

    24.1. USA Rotavirus Prophylaxis Market Overview

    24.2. USA Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Rotavirus Prophylaxis Market  

    25.1. Canada Rotavirus Prophylaxis Market Overview

    25.2. Canada Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Rotavirus Prophylaxis Market  

    26.1. South America Rotavirus Prophylaxis Market Overview

    26.2. South America Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Rotavirus Prophylaxis Market  

    27.1. Brazil Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Rotavirus Prophylaxis Market  

    28.1. Middle East Rotavirus Prophylaxis Market Overview

    28.2. Middle East Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Rotavirus Prophylaxis Market  

    29.1. Africa Rotavirus Prophylaxis Market Overview

    29.2. Africa Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Rotavirus Prophylaxis Market Competitive Landscape And Company Profiles

    30.1. Rotavirus Prophylaxis Market Competitive Landscape

    30.2. Rotavirus Prophylaxis Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Merck & Co.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Novartis AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Sanofi SA

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Rotavirus Prophylaxis Market Other Major And Innovative Companies

    31.1. Astra Zeneca Pharmaceuticals LP

    31.2. GlaxoSmithKline plc

    31.3. Takeda Pharmaceutical Company Limited

    31.4. Sinovac Biotech Ltd.

    31.5. Astellas Pharma Inc.

    31.6. CSL Limited  

    31.7. Bharat Biotech International Limited

    31.8. Daiichi Sankyo Co. Ltd.

    31.9. Lupin Limited

    31.10. Mitsubishi Tanabe Pharma Corporation  

    31.11. Serum Institute of India Pvt. Ltd.

    31.12. Zydus Lifescience Ltd.

    31.13. Emergent BioSolutions Inc.

    31.14. Hualan Biological Engineering Inc.

    31.15. Biocad Biopharmaceutical Co.

    32. Global Rotavirus Prophylaxis Market Competitive Benchmarking

    33. Global Rotavirus Prophylaxis Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Rotavirus Prophylaxis Market

    35. Rotavirus Prophylaxis Market Future Outlook and Potential Analysis

    35.1 Rotavirus Prophylaxis Market In 2028 - Countries Offering Most New Opportunities

    35.2 Rotavirus Prophylaxis Market In 2028 - Segments Offering Most New Opportunities

    35.3 Rotavirus Prophylaxis Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Rotavirus Prophylaxis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Rotavirus Prophylaxis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Johnson & Johnson Financial Performance
  • Table 77: Merck & Co. Financial Performance
  • Table 78: Novartis AG Financial Performance
  • Table 79: Sanofi SA Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Rotavirus Prophylaxis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Rotavirus Prophylaxis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Johnson & Johnson Financial Performance
  • Figure 77: Merck & Co. Financial Performance
  • Figure 78: Novartis AG Financial Performance
  • Figure 79: Sanofi SA Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Cancer Vaccines Global Market Report 2024 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat, Other Cancer Types), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
DTP Vaccines Global Market Report 2024 – By Product type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End-User (Hospitals, Clinics, Vaccination Centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Companion Animal Veterinary Vaccines Global Market Report 2024 – By Product (Inactivated, Live Attenuated, Recombinant, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pediatric Vaccine Global Market Report 2024 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, Cancer) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Veterinary Vaccines Global Market Report 2024 – By Application (Livestock Vaccines, Companion Animal Vaccines), By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types), By Disease Type (Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Meningococcal Vaccines Global Market Report 2024 – By Vaccine Type (Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine), By Serotype (Men Acwy, Men B/Bc, Men C), By Age Group (Infants, Children, Adolescents and Young Adults, Adults), By Distribution Channel ( (Pharmacies, Community Clinics, Public Health Agencies, Other Channels), By End user (Hospitals, Research, Academic Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Swine Vaccines Global Market Report 2024 – By Product( Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA (Deoxyribonucleic Acid) Vaccines, Recombinant Vaccines), By Disease( Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Other Diseases), By Distribution Channel( Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies), By Application( Government Tender, Market Sales) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Typhoid Vi Polysaccharide Vaccine Global Market Report 2024 – By Type( Child, Adult ), By Route of Administration( Oral, Parenteral ), By Application( Government Institution, Private Sector, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the rotavirus prophylaxis market?

Rotavirus prophylaxis refers to the prevention of rotavirus infection through vaccination, which protects infants and young children from a highly infectious illness that causes stomach and bowel inflammation. The purpose is to protect from person from any severity. request a sample here

How will the rotavirus prophylaxis market drivers and restraints affect the rotavirus prophylaxis market dynamics? What forces will shape the rotavirus prophylaxis industry going forward?

The rotavirus prophylaxis market major growth driver - Rising Vaccine Courses Powering Growth In The Rotavirus Prophylaxis Market. request a sample here

What is the forecast market size or the forecast market value of the rotavirus prophylaxis market?

The rotavirus prophylaxis market size has grown rapidly in recent years. It will grow from $8.15 billion in 2023 to $9.05 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to vaccine access and equity, emerging rotavirus strains, r&d investments, public health preparedness. The rotavirus prophylaxis market size is expected to see strong growth in the next few years. It will grow to $13.24 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to gastrointestinal disease burden, global expansion, vaccination programs, vaccine confidence. Major trends in the forecast period include next-generation vaccines, combination vaccines, vaccine delivery innovation, global immunization collaboration. request a sample here

How is the rotavirus prophylaxis market segmented?

The rotavirus prophylaxis market is segmented
1) By Treatment: Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments
2) By Route of Administration: Oral, Parenteral, Other Route of Administrations
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-UsersFor further insights on the rotavirus prophylaxis market request a sample here

Which region has the largest share of the rotavirus prophylaxis market? What are the other regions covered in the report?

North America was the largest region in the rotavirus prophylaxis market in 2023. The regions covered in rotavirus prophylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the rotavirus prophylaxis market?

Major players in the rotavirus prophylaxis market are Pfizer Inc., Johnson & Johnson, Merck & Co., Novartis AG, Sanofi SA, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd., Astellas Pharma Inc., CSL Limited, Bharat Biotech International Limited, Daiichi Sankyo Co. Ltd., Lupin Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., Zydus Lifescience Ltd., Emergent BioSolutions Inc., Hualan Biological Engineering Inc., Biocad Biopharmaceutical Co., Bharat Serums and Vaccines Limited, Biological E Limited, PT Bio Farma, Panacea Biotec Ltd., Shanghai Institute of Biological Products (SIBP). request a sample here.

What are the key trends in the rotavirus prophylaxis market?

Major trend in the rotavirus prophylaxis market - Vaccine Development And Approvals In The Rotavirus Prophylaxis Market. request a sample here.

What are the major opportunities in the rotavirus prophylaxis market? What are the strategies for the rotavirus prophylaxis market?

For detailed insights on the major opportunities and strategies in the rotavirus prophylaxis market, request a sample here.

How does the rotavirus prophylaxis market relate to the overall economy and other similar markets?

For detailed insights on rotavirus prophylaxis market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the rotavirus prophylaxis industry?

For detailed insights on the mergers and acquisitions in the rotavirus prophylaxis industry, request a sample here.

What are the key dynamics influencing the rotavirus prophylaxis market growth? SWOT analysis of the rotavirus prophylaxis market.

For detailed insights on the key dynamics influencing the rotavirus prophylaxis market growth and SWOT analysis of the rotavirus prophylaxis industry, request a sample here.